We are live on ! Find out more
AA

Antipodean Advisors Portfolio holdings

AUM $19.5M
1-Year Est. Return 6.21%
This Fund
S&P 500
This Quarter Est. Return
+14.28%
1 Year Est. Return
-6.21%
3 Year Est. Return
-67.79%
5 Year Est. Return
+67.26%
10 Year Est. Return
+1,117.22%
AUM
$1.34B
AUM Growth
+$267M
Cap. Flow
+$134M
Cap. Flow %
10.03%
Top 10 Hldgs %
82.77%
Holding
27
New
10
Increased
3
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
SNDK
SANDISK CORP
SNDK
+$89.3M
2
MU icon
Micron Technology
MU
+$78.2M
3
RL icon
Ralph Lauren
RL
+$46.4M
4
BHC icon
Bausch Health
BHC
+$39.8M
5
NFLX icon
Netflix
NFLX
+$27.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 16.94%
3 Energy 12.9%
4 Consumer Staples 9.28%
5 Communication Services 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNG icon
1
Cheniere Energy
LNG
$54.2B
$173M 12.9%
2,409,000
-100,000
-4% -$6.07M
BHC icon
2
Bausch Health
BHC
$1.75B
$147M 10.98%
1,165,200
+312,000
+37% +$39.8M
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$144M 10.76%
1,943,000
WDAY icon
4
Workday
WDAY
$41.5B
$106M 7.92%
1,179,205
+253,205
+27% +$19.9M
STZ icon
5
Constellation Brands
STZ
$22.5B
$104M 7.8%
1,184,000
-216,000
-15% -$17.8M
SNDK
6
DELISTED
SANDISK CORP
SNDK
$103M 7.68%
+984,000
New +$89.3M
MU icon
7
Micron Technology
MU
$835B
$94.5M 7.06%
+2,869,000
New +$78.2M
CHTR icon
8
Charter Communications
CHTR
$17.3B
$89.2M 6.66%
563,142
+84,000
+18% +$11.6M
ENDP
9
DELISTED
Endo International plc
ENDP
$73.9M 5.52%
1,056,000
-54,000
-5% -$3.61M
ILMN icon
10
Illumina
ILMN
$29.5B
$73.5M 5.49%
423,022
-20,406
-5% -$3.04M
RL icon
11
Ralph Lauren
RL
$22.4B
$48.4M 3.61%
+301,000
New +$46.4M
HRB icon
12
H&R Block
HRB
$5.98B
$37.1M 2.77%
1,106,273
-738,927
-40% -$22M
NFLX icon
13
Netflix
NFLX
$307B
$31.7M 2.37%
+5,040,000
New +$27.3M
NRF
14
DELISTED
NorthStar Realty Finance Corp.
NRF
$30.2M 2.25%
884,058
-1,215,071
-58% -$38.3M
DATA
15
DELISTED
Tableau Software, Inc.
DATA
$25.1M 1.88%
+352,000
New +$22.1M
MDLZ icon
16
Mondelez International
MDLZ
$83.4B
$19.9M 1.49%
+530,000
New +$19.4M
AZN icon
17
AstraZeneca
AZN
$269B
$19.8M 1.48%
+266,000
New +$19.2M
RAD
18
DELISTED
Rite Aid Corporation
RAD
$10.9M 0.82%
+76,100
New +$11.2M
SHLD
19
DELISTED
Sears Holding Corporation
SHLD
$5.28M 0.39%
141,726
-235,612
-62% -$8.72M
CSLT
20
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.16M 0.09%
+76,000
New +$1.24M
SODA
21
DELISTED
SodaStream International Ltd
SODA
$1.11M 0.08%
+33,000
New +$1.3M
AX icon
22
Axos Financial
AX
$5.58B
-560,000
Closed -$12M
PARA
23
DELISTED
Paramount Global Class B
PARA
-394,000
Closed -$24.3M
JCP
24
DELISTED
J.C. Penney Company, Inc.
JCP
-3,171,000
Closed -$27.3M
UNIS
25
DELISTED
Unilife Corporation
UNIS
-178,400
Closed -$7.26M

Similar funds

Antipodean Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Antipodean Advisors held 27 positions worth $1.34B, up 25% from $1.07B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Antipodean Advisors deployed $134M of net new capital in Q2 2014, opening 10 new positions and adding to 3 existing holdings. Its largest new stake was SANDISK CORP: 984,000 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was NorthStar Realty Finance Corp., an estimated $38.3M trimmed.

  • Antipodean Advisors's largest Q2 2014 buy was SANDISK CORP: 984,000 shares worth $103M.
  • Antipodean Advisors added most to Bausch Health in Q2 2014, an estimated $39.8M increase.
  • Antipodean Advisors's biggest Q2 2014 reduction was NorthStar Realty Finance Corp., cutting an estimated $38.3M.
  • Antipodean Advisors fully exited LinkedIn Corporation in Q2 2014, selling an estimated $63.9M.
  • Antipodean Advisors's ten largest holdings make up 83% of its $1.34B portfolio in Q2 2014.
  • Antipodean Advisors opened 10 new positions and closed 6 in Q2 2014.
  • Antipodean Advisors's portfolio value rose 25% quarter-over-quarter to $1.34B.

Based on Antipodean Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.